FDA grants accelerated approval for Biogen ALS drug that treats rare form of the disease
April 25, 2023 at 13:20 PM EDT
The FDA's approval requires Biogen to further study its ALS drug tofersen to further verify its clinical benefits.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|